2020-2027 Analysis and Review Ganciclovir Market

Ganciclovir Market

Ganciclovir Market By Clinical Application (CMV Retinitis, CMV Pneumonitis and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

26-06-2020 REP-HC-5126 40 Tables 120 pages Format

The ganciclovir market was valued at USD 393.3 Mn by 2019. Rising prevalence of cytomegalovirus (CMV) retinitis in immunocompromised patients worldwide primarily drives the ganciclovir market growth. Additionally, the high mortality rate associated with CMV pneumonitis infection in patients undergoing solid organ transplantation further accentuates the market growth in the region.

Ganciclovir Market

Ganciclovir is basically an antiviral drug which is a synthetic nucleoside analogue of 2'-deoxyguanosine which is involved in the inhibition of replication of herpes virus by getting incorporated in the viral DNA. It is available as a lyophilized powder for a solution to be injected in a concentration of 50 mg/1mL and capsules of dose strength of 500mg and 250 mg accordingly.

The major segments related to the ganciclovir market are: 

By Clinical Application (2017–2027; US$ Mn)

Cytomegalovirus (CMV) Retinitis

Cytomegalovirus (CMV) Pneumonitis

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global ganciclovir market
  • The overall segmentation of the ganciclovir market, by clinical application, distribution channel, and geography is minutely studied. Cytomegalovirus (CMV) retinitis and hospital pharmacy are dominating the clinical application and distribution channel segments respectively
  • Rising prevalence of cytomegalovirus retinitis infection in immunocompromised patients worldwide
  • Significant growth in the number of patients suffering from cytomegalovirus pneumonitis recently received a solid organ or bone marrow transplant

Report gist?

  • The study of the global ganciclovir market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers the qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of ganciclovir due to the  rising prevalence of cytomegalovirus retinitis in immunocompromised patients worldwide
  • The report will benefit physicians prescribing ganciclovir for treating CMV pneumonitis in patients recently received a solid organ or bone marrow transplant
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to ganciclovir market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Cytomegalovirus (CMV) retinitis is representing the largest market share in the clinical application segment for the ganciclovir market. As per the latest research citings provided by the World Health Organization (WHO), approximately 40% of the people suffering from AIDS worldwide develop CMV retinitis during the later stage of their lives. The effective diagnosis of CMV retinitis can be performed with CD8+ T-lymphocyte count and ophthalmic screening frequency is based on CD4 count etc. It is basically the inflammation of the retina of the eye which if not adequately treated may lead to permanent blindness. Cytomegalovirus (CMV) pneumonitis is expected to be recording comfortable market growth during the forecast period. Patients who have undergone bone marrow transplant or solid organ transplants are at a greater risk of acquiring CMV pneumonitis. The incidence rate of the disease is 35% after allogeneic transplantation and 6% after autologous transplantation respectively.

Hospital pharmacy is presently dominating the distribution channel segment for the ganciclovir market. Judicious use of ganciclovir is imperative as it possesses teratogenicity properties, hence drug compounding needs to be done under the supervision of a trained hospital pharmacist. Retail pharmacy is gaining huge demand in the developing regions of the world primarily due to proactive initiative by government healthcare authorities to provide subsidized antiviral drugs in retail pharmacy at affordable prices and the ability to cater medicinal requirements of patients residing in remote locations.

North America is currently leading the geography segment for the ganciclovir market. The rising prevalence of cytomegalovirus retinitis infection in the immunocompromised patients primarily drives the ganciclovir market growth in the region. As per the statistics provided by the Center for Disease Control and Prevention (CDC), approximately 1 in 3 children by age 5 are already infected with cytomegalovirus in the United States. Furthermore, affordable reimbursement scenarios associated with the use of ganciclovir drug formulation further consolidate the market growth in the region. Europe is the second-largest regional segment in the ganciclovir market, primarily due to the rising prevalence of cytomegalovirus (CMV) pneumonitis in patients who have recently received a solid organ or bone marrow transplant in the region. Asia Pacific is anticipated to be the fastest-growing regional segment for the ganciclovir market owing to the rising prevalence of CMV infection in people suffering from AIDS and the flourishing generic drugs market.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.